Wave Ev To Sales vs Price To Sales Ratio Analysis

WVE Stock

USD 15.10 0.11 0.73%

Wave Life financial indicator trend analysis is more than just analyzing Wave Life Sciences current accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Wave Life Sciences is a good investment. Please check the relationship between Wave Life Ev To Sales and its Price To Sales Ratio accounts. Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Wave Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.

Ev To Sales vs Price To Sales Ratio

Ev To Sales vs Price To Sales Ratio Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Wave Life Sciences Ev To Sales account and Price To Sales Ratio. At this time, the significance of the direction appears to have weak contrarian relationship.

The correlation between Wave Life's Ev To Sales and Price To Sales Ratio is -0.04. Overlapping area represents the amount of variation of Ev To Sales that can explain the historical movement of Price To Sales Ratio in the same time period over historical financial statements of Wave Life Sciences, assuming nothing else is changed. The correlation between historical values of Wave Life's Ev To Sales and Price To Sales Ratio is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Ev To Sales of Wave Life Sciences are associated (or correlated) with its Price To Sales Ratio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Price To Sales Ratio has no effect on the direction of Ev To Sales i.e., Wave Life's Ev To Sales and Price To Sales Ratio go up and down completely randomly.

Correlation Coefficient

-0.04

Relationship Direction	Negative
Relationship Strength	Insignificant

View All Relationships

Ev To Sales

The Enterprise Value to Sales ratio, a valuation metric used to compare the value of a company, including debt and excluding cash, to its sales revenue.

Price To Sales Ratio

Price to Sales Ratio is figured by comparing Wave Life Sciences stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Wave Life sales, a figure that is much harder to manipulate than other Wave Life Sciences multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.

Most indicators from Wave Life's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Wave Life Sciences current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Wave Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.

As of November 29, 2024, Selling General Administrative is expected to decline to about 33.7 M. The current year's Tax Provision is expected to grow to about (643.1 K)

Wave Life fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Other Assets	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Current Assets	Total Liab	Property Plant And Equipment Gross	Preferred Stock Total Equity	Total Current Assets	Short Term Debt	Common Stock
Total Assets		0.52	0.86	0.75	0.56	0.76	0.86	0.74	-0.9	-0.67	0.83	0.96	0.83	0.58	0.96	0.69	0.76	0.44	0.72	0.86	0.85	0.78	0.8	0.98	-0.12	0.79
Short Long Term Debt Total	0.52		0.67	0.67	-0.32	0.76	0.81	0.61	-0.23	-0.87	0.72	0.38	0.6	0.19	0.38	0.56	0.8	0.67	0.79	0.68	0.83	0.74	0.31	0.45	0.6	0.85
Other Current Liab	0.86	0.67		0.72	0.19	0.85	0.95	0.67	-0.63	-0.72	0.86	0.71	0.96	0.7	0.71	0.54	0.75	0.49	0.89	0.86	0.91	0.79	0.67	0.76	0.0	0.79
Total Current Liabilities	0.75	0.67	0.72		0.07	0.9	0.75	0.99	-0.64	-0.84	0.74	0.65	0.71	0.42	0.65	0.85	0.86	0.81	0.61	0.8	0.84	0.96	0.51	0.71	0.42	0.75
Total Stockholder Equity	0.56	-0.32	0.19	0.07		-0.03	0.13	0.1	-0.77	0.08	0.15	0.7	0.18	0.19	0.7	0.21	0.09	-0.18	-0.03	0.16	0.03	0.1	0.55	0.65	-0.64	0.1
Other Liab	0.76	0.76	0.85	0.9	-0.03		0.85	0.85	-0.6	-0.92	0.83	0.65	0.78	0.46	0.65	0.59	0.91	0.81	0.83	0.85	0.91	0.93	0.6	0.68	0.39	0.86
Property Plant And Equipment Net	0.86	0.81	0.95	0.75	0.13	0.85		0.69	-0.6	-0.81	0.89	0.71	0.91	0.55	0.71	0.64	0.83	0.53	0.93	0.9	0.94	0.82	0.65	0.77	0.13	0.87
Current Deferred Revenue	0.74	0.61	0.67	0.99	0.1	0.85	0.69		-0.64	-0.79	0.68	0.64	0.67	0.42	0.64	0.87	0.81	0.78	0.54	0.76	0.8	0.93	0.5	0.7	0.39	0.69
Net Debt	-0.9	-0.23	-0.63	-0.64	-0.77	-0.6	-0.6	-0.64		0.54	-0.65	-0.97	-0.57	-0.35	-0.97	-0.58	-0.68	-0.42	-0.47	-0.66	-0.59	-0.67	-0.81	-0.95	0.2	-0.63
Retained Earnings	-0.67	-0.87	-0.72	-0.84	0.08	-0.92	-0.81	-0.79	0.54		-0.83	-0.61	-0.59	-0.13	-0.61	-0.62	-0.98	-0.9	-0.77	-0.77	-0.84	-0.92	-0.59	-0.64	-0.54	-0.94
Accounts Payable	0.83	0.72	0.86	0.74	0.15	0.83	0.89	0.68	-0.65	-0.83		0.74	0.77	0.41	0.74	0.59	0.84	0.62	0.83	0.9	0.9	0.79	0.7	0.78	0.15	0.89
Cash	0.96	0.38	0.71	0.65	0.7	0.65	0.71	0.64	-0.97	-0.61	0.74		0.65	0.39	1.0	0.59	0.72	0.41	0.58	0.75	0.7	0.69	0.83	0.99	-0.17	0.75
Non Current Assets Total	0.83	0.6	0.96	0.71	0.18	0.78	0.91	0.67	-0.57	-0.59	0.77	0.65		0.85	0.65	0.59	0.62	0.34	0.85	0.83	0.89	0.71	0.56	0.7	-0.07	0.65
Other Assets	0.58	0.19	0.7	0.42	0.19	0.46	0.55	0.42	-0.35	-0.13	0.41	0.39	0.85		0.39	0.33	0.16	-0.05	0.54	0.52	0.58	0.33	0.3	0.44	-0.34	0.2
Cash And Short Term Investments	0.96	0.38	0.71	0.65	0.7	0.65	0.71	0.64	-0.97	-0.61	0.74	1.0	0.65	0.39		0.59	0.72	0.41	0.58	0.75	0.7	0.69	0.83	0.99	-0.17	0.75
Net Receivables	0.69	0.56	0.54	0.85	0.21	0.59	0.64	0.87	-0.58	-0.62	0.59	0.59	0.59	0.33	0.59		0.66	0.54	0.42	0.66	0.69	0.77	0.42	0.68	0.25	0.59
Common Stock Total Equity	0.76	0.8	0.75	0.86	0.09	0.91	0.83	0.81	-0.68	-0.98	0.84	0.72	0.62	0.16	0.72	0.66		0.87	0.77	0.79	0.84	0.94	0.67	0.75	0.43	0.94
Common Stock Shares Outstanding	0.44	0.67	0.49	0.81	-0.18	0.81	0.53	0.78	-0.42	-0.9	0.62	0.41	0.34	-0.05	0.41	0.54	0.87		0.47	0.55	0.61	0.87	0.42	0.44	0.67	0.74
Non Current Liabilities Total	0.72	0.79	0.89	0.61	-0.03	0.83	0.93	0.54	-0.47	-0.77	0.83	0.58	0.85	0.54	0.58	0.42	0.77	0.47		0.81	0.89	0.69	0.57	0.62	0.15	0.81
Other Current Assets	0.86	0.68	0.86	0.8	0.16	0.85	0.9	0.76	-0.66	-0.77	0.9	0.75	0.83	0.52	0.75	0.66	0.79	0.55	0.81		0.93	0.8	0.62	0.8	0.16	0.84
Total Liab	0.85	0.83	0.91	0.84	0.03	0.91	0.94	0.8	-0.59	-0.84	0.9	0.7	0.89	0.58	0.7	0.69	0.84	0.61	0.89	0.93		0.85	0.61	0.76	0.25	0.89
Property Plant And Equipment Gross	0.78	0.74	0.79	0.96	0.1	0.93	0.82	0.93	-0.67	-0.92	0.79	0.69	0.71	0.33	0.69	0.77	0.94	0.87	0.69	0.8	0.85		0.61	0.74	0.42	0.85
Preferred Stock Total Equity	0.8	0.31	0.67	0.51	0.55	0.6	0.65	0.5	-0.81	-0.59	0.7	0.83	0.56	0.3	0.83	0.42	0.67	0.42	0.57	0.62	0.61	0.61		0.82	-0.33	0.7
Total Current Assets	0.98	0.45	0.76	0.71	0.65	0.68	0.77	0.7	-0.95	-0.64	0.78	0.99	0.7	0.44	0.99	0.68	0.75	0.44	0.62	0.8	0.76	0.74	0.82		-0.13	0.78
Short Term Debt	-0.12	0.6	0.0	0.42	-0.64	0.39	0.13	0.39	0.2	-0.54	0.15	-0.17	-0.07	-0.34	-0.17	0.25	0.43	0.67	0.15	0.16	0.25	0.42	-0.33	-0.13		0.33
Common Stock	0.79	0.85	0.79	0.75	0.1	0.86	0.87	0.69	-0.63	-0.94	0.89	0.75	0.65	0.2	0.75	0.59	0.94	0.74	0.81	0.84	0.89	0.85	0.7	0.78	0.33

Click cells to compare fundamentals

Wave Life Account Relationship Matchups

Wave Life fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	284.3M	279.2M	207.0M	146.4M	274.9M	200.5M
Short Long Term Debt Total	32.5M	29.3M	29.9M	37.6M	32.1M	20.4M
Other Current Liab	16.2M	8.3M	9.9M	12.1M	10.1M	8.5M
Total Current Liabilities	118.2M	121.0M	64.2M	71.5M	186.4M	195.8M
Total Stockholder Equity	63.7M	82.8M	32.5M	(45.1M)	47.5M	49.3M
Other Liab	65.2M	42.0M	77.5M	80.0M	92.0M	96.6M
Property Plant And Equipment Net	54.5M	45.4M	40.6M	44.1M	35.7M	30.2M
Current Deferred Revenue	89.7M	91.6M	37.1M	31.6M	150.1M	157.6M
Net Debt	(114.6M)	(155.2M)	(120.6M)	(50.9M)	(168.2M)	(176.6M)
Retained Earnings	(533.4M)	(683.3M)	(805.5M)	(967.3M)	(1.0B)	(973.6M)
Accounts Payable	9.1M	13.8M	7.3M	16.9M	12.8M	8.9M
Cash	147.2M	184.5M	150.6M	88.5M	200.4M	140.1M
Non Current Assets Total	98.8M	49.2M	44.4M	47.8M	39.6M	42.5M
Other Assets	44.3M	3.8M	3.8M	3.7M	4.3M	4.1M
Cash And Short Term Investments	147.2M	184.5M	150.6M	88.5M	200.4M	140.1M
Net Receivables	10M	20M	30M	0.0	21.1M	22.1M
Common Stock Total Equity	539.5M	694.1M	749.9M	802.8M	923.3M	969.4M
Common Stock Shares Outstanding	33.9M	39.2M	51.8M	78.9M	106.1M	111.4M
Liabilities And Stockholders Equity	284.3M	279.2M	207.0M	146.4M	274.9M	200.5M
Non Current Liabilities Total	102.4M	75.4M	110.3M	120.0M	41.0M	59.0M
Other Current Assets	8.7M	15.5M	12M	10.0M	13.9M	8.7M
Total Liab	220.5M	196.5M	174.5M	191.5M	227.4M	132.8M
Property Plant And Equipment Gross	54.5M	45.4M	40.6M	44.1M	78.4M	82.4M
Total Current Assets	185.5M	230.0M	162.6M	98.5M	235.4M	158.0M
Accumulated Other Comprehensive Income	267K	389K	181K	(29K)	(124K)	(117.8K)
Short Term Debt	3.2M	7.4M	9.9M	11.0M	13.4M	14.1M
Common Stock	539.5M	694.1M	749.9M	802.8M	935.4M	481.8M
Property Plant Equipment	54.5M	29.2M	22.3M	17.3M	19.9M	22.5M
Net Tangible Assets	63.7M	90.7M	40.4M	(37.2M)	(33.5M)	(31.8M)
Other Stockholder Equity	49.4M	63.7M	80.1M	111.6M	129.2M	135.7M
Non Currrent Assets Other	10.7M	115K	148K	62K	3.9M	6.9M
Capital Surpluse	57.3M	71.6M	88.0M	119.4M	137.4M	144.2M
Capital Lease Obligations	32.5M	29.3M	29.9M	37.6M	32.1M	21.5M
Non Current Liabilities Other	1.7M	67.5M	102.4M	112.1M	128.9M	135.3M
Net Invested Capital	63.7M	82.8M	32.5M	(45.1M)	39.6M	44.2M
Net Working Capital	67.3M	109.0M	98.4M	27.0M	48.9M	63.3M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

V	Visa Class A
GOOG	Alphabet Inc Class C
GOOG	Alphabet Inc Class C

When determining whether Wave Life Sciences is a strong investment it is important to analyze Wave Life's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Wave Life's future performance. For an informed investment choice regarding Wave Stock, refer to the following important reports:

How To Invest In Wave

Details

Is Wave Stock a good investment?

Details

What is Wave Life's Net Worth?

Details

Largest Pharmaceuticals Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Wave Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.

You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.

Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Wave Life. If investors know Wave will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Wave Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(1.12)

Revenue Per Share

0.427

Quarterly Revenue Growth

(0.11)

Return On Assets

(0.34)

Return On Equity

(2.44)

The market value of Wave Life Sciences is measured differently than its book value, which is the value of Wave that is recorded on the company's balance sheet. Investors also form their own opinion of Wave Life's value that differs from its market value or its book value, called intrinsic value, which is Wave Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Wave Life's market value can be influenced by many factors that don't directly affect Wave Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Wave Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if Wave Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Wave Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Wave Ev To Sales vs Price To Sales Ratio Analysis

Ev To Sales vs Price To Sales Ratio

Ev To Sales vs Price To Sales Ratio Correlation Analysis

Correlation Coefficient

Ev To Sales

Price To Sales Ratio

Wave Life fundamental ratios Correlations

Wave Life Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Wave Life fundamental ratios Accounts

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Cash
Current Deferred Revenue	+ 0.99	Total Current Liabilities
Total Current Assets	+ 0.99	Cash
Total Current Assets	+ 0.99	Cash And Short Term Investments
Total Current Assets	+ 0.98	Total Assets
Cash	+ 0.96	Total Assets

Common Stock Total Equity	- 0.98	Retained Earnings
Cash And Short Term Investments	- 0.97	Net Debt
Cash	- 0.97	Net Debt
Total Current Assets	- 0.95	Net Debt
Common Stock	- 0.94	Retained Earnings
Property Plant And Equipment Gross	- 0.92	Retained Earnings